Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News MethylGene Inc MYLGF

Healthcare Biotechnology
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (GREY:MYLGF)

LifeSci Advisors Initiates Coverage of Mirati Therapeutics

Marketwired July 18, 2013

Mirati Therapeutics to Commence Trading on the NASDAQ

Marketwired July 15, 2013

Mirati Therapeutics and MethylGene Announce Completion of Plan of Arrangement

Marketwired June 28, 2013

Mirati Therapeutics and MethylGene Announce Completion of Plan of Arrangement

Marketwired June 28, 2013

MethylGene Shareholders Approve the Plan of Arrangement to Reincorporate in the United States as Mirati Therapeutics Inc.

Marketwired June 25, 2013

MethylGene Shareholders Approve the Plan of Arrangement to Reincorporate in the United States as Mirati Therapeutics Inc.

Marketwired June 25, 2013

MethylGene Presents Clinical Data on Mocetinostat at the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting

Marketwired June 3, 2013

MethylGene Presents Clinical Data on Mocetinostat at the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting

Marketwired June 3, 2013

MethylGene to Present at the Jefferies 2013 Healthcare Conference

Marketwired May 30, 2013
View More News ››

Opinion & Analysis (GREY:MYLGF)

No current opinion is available.
View More Opinion ››

Bullboard Posts (GREY:MYLGF)

Piper Jaffray Starts Mirati Therapeutics (MRTX) at Overweight

Piper Jaffray initiates coverage on Mirati Therapeutics (NASDAQ:MRTX) with a Overweight. PT $22.00.
Jimmyplant - August 15, 2013

Mirati Therapeutics: Revamped And Ready To Go With A Targeted Oncology Pipeline

http://seekingalpha.com/article/1562922-mirati-therapeutics-revamped-and-ready-to-go-with-a-targeted-oncology-pipeline
Jimmyplant - July 24, 2013

why sudden jump?

anyone?
Jimmyplant - May 24, 2013

RE: New low..tiime for a boucne after big % drop

Looking good, cheapies were had, bounce looks good for more as buyers keep showing up to pick up any sells...any half decent news will...
gmarc66 - April 25, 2013

New low..tiime for a boucne after big % drop

Get them cheap for a bounce play..glta
gmarc66 - April 24, 2013

New low..tiime for a boucne after big % drop

Get them cheap for a bounce play..glta
gmarc66 - April 24, 2013
View more Bullboard ››

Viva Gold Corp.

Viva Gold Corp.

Viva Gold Corp. is a Canada-based gold exploration and development company, The Company’s business is the acquisition ...
View More »